Clinical Trial

Myocardial Infarction Clinical Trial 20213053

[LCID Study Number: 20213053]

The AMPLATZER Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

The purpose of this study is to evaluate the safety and probable benefit of the AMPLATZER PIVSD Occluder for use in transcatheter closure of muscular ventricular septal defects following a myocardial infarction in the post approval setting.

Disease/Condition: Myocardial Infarction

Department: Cardiovascular Medicine

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Primary Contact Phone: 781-744-1901

Clinical Trial Details

View NCT ID 03165526 on

Protocol #: 20213053

Principal Investigator(s): Thomas C. Piemonte

Study Coordinator(s): Jean Byrne

Trial Phase: Humanitarian Use Device